Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001521806-15-000001
Filing Date
2015-04-29
Accepted
2015-04-29 21:51:45
Documents
1
Period of Report
2015-04-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3041
  Complete submission text file 0001521806-15-000001.txt   4789
Mailing Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310
Business Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Issuer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address BOJIN GONGGUAN 2 ZUO 12 CENG 1216 GUANG AN STREET SHIJIAZHUANG F4 050011
Business Address
Zhang Guoan (Reporting) CIK: 0001521806 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32674 | Film No.: 15814893